No effects of lifelong creatine supplementation on sarcopenia in senescence-accelerated mice (SAMP8)

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 2 52-2, 2005, Pages

  Derave, Wim ^a,b   Eijnde, Bert O ^a   Ramaekers, Monique ^a   Hespel, Peter ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Faculty of Kinesiology and Rehabilitation Sciences   (Belgium)

Author keywords

Atrophy; Contractile properties; Muscle fiber

Indexed keywords

CREATINE; CREATINE PHOSPHATE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXTENSOR DIGITORUM LONGUS MUSCLE; FAST MUSCLE; FOOD INTAKE; GLYCOLYSIS; IN VITRO STUDY; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CONTRACTILITY; MUSCLE FUNCTION; MUSCLE LEVEL; MUSCLE MASS; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; SKELETAL MUSCLE;

AGING; ANIMALS; CREATINE; DIETARY SUPPLEMENTS; ENERGY METABOLISM; MALE; MICE; MICE, INBRED STRAINS; MUSCLE CONTRACTION; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; ORGAN SIZE; TREATMENT OUTCOME;

EID: 23044482646     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00039.2005     Document Type: Article

References (29)

1. Chrusch MJ, Chilibeck PD, Chad KE, Davison KS, and Burke DG. Creatine supplementation combined with resistance training in older men. Med Sci Sports Exerc 33: 2111-2117, 2001.
2. Derave W, Eijnde BO, and Hespel P. Creatine supplementation in health and disease: what is the evidence for long-term efficacy? Mol Cell Biochem 244: 49-55, 2003.
3. Derave W, Van Den Bosch L, Lemmens G, Eijnde BO, Robberecht W, and Hespel P. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment. Neurobiol Dis 13: 264-272, 2003.
4. Eijnde BO, Van Leemputte M, Goris M, Labarque V, Taes Y, Verbessern P, Vanhees L, Ramaekers M, Vanden Eynde B, Van Schuylenbergh R, Dom R, Richter EA, and Hespel P. Effects of creatine supplementation and exercise training on fitness in males 55 to 75 years old. J Appl Physiol 95: 818-828, 2003.
5. Gotshalk LA, Volek JS, Staron RS, Denegar CR, Hagerman FC, and Kraemer WJ. Creatine supplementation improves muscular performance in older men. Med Sci Sports Exerc 34: 537-543, 2002.
6. Greenhaff PL, Bodin K, Soderlund K, and Hultman E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol Endocrinol Metab 266: E725-E730, 1994.
7. Greenland LJ and Nair KS. Sarcopenia-consequences, mechanisms, and potential therapies. Mech Ageing Dev 124: 287-299, 2003.
8. Groeneveld GJ, Veldink JH, van der Tweel I, Kalmijn S, Beijer C, de Visser M, Wokke JH, Franssen H, and van den Berg LH. A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Ann Neurol 53: 437-445, 2003.
9. Harris RC, Söderlund K, and Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Colch) 83: 367-374, 1992.
10. Hespel P, Eijnde BO, Derave W, and Richter EA. Creatine supplementation: exploring the role of the creatine kinase/phosphocreatine system in human muscle. Can J Appl Physiol 26: S79-S102, 2001.
11. Hespel P, Op 't Eijnde B, Van Leemputte M, Urso B, Greenhaff PL, Labarque V, Dymarkowski S, Van Hecke P, and Richter EA. Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters expression of muscle myogenic factors in humans. J Physiol 536: 625-633, 2001.
12. Hultman E, Soderlund K, Timmons JA, Cederblad G, and Greenhaff PL. Muscle creatine loading in men. J Appl Physiol 81: 232-237, 1996.
13. Item CB, Stockler-Ipsiroglu S, Stromberger C, Muhl A, Alessandri MG, Bianchi MC, Tosetti M, Fornai F, and Cioni G. Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet 69: 1127-1133, 2001.
14. Klivenyi P, Ferrante J, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, and Beal MF. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5: 347-350, 1999.
15. Lowry OH and Passonneau JV. A Flexible System of Enzymatic Analysis. London, UK: Academic, 1972.
16. Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, and Beal MF. Neuroprotective effect of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci 18: 156-163, 1998.
17. Mazzini L, Balzarini C, Colombo R, Mora G, Pastore I, De Ambrogio R, and Caligari M. Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results. J Neurol Sci 191: 139-144, 2001.
18. McKenzie D, Bua E, McKiernan S, Cao Z, and Aiken JM. Mitochondrial DNA deletion mutations: a causal role in sarcopenia. Eur J Biochem 269: 2010-2015, 2002.
19. Op 't Eijnde B, Richter EA, Henquin JC, Kiens B, and Hespel P. Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle. Acta Physiol Scand 171: 169-176, 2001.
20. Sipilä I, Rapola J, Simell O, and Vannas A. Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N Engl J Med 304: 867-870, 1981.
21. Stockler S, Hanefeld F, and Frahm J. Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 348: 789-790, 1996.
22. Tabrizi SJ, Blamire AM, Manners DN, Rajagopalan B, Styles P, Schapira AH, and Warner TT. Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study. Neurology 61: 141-142, 2003.
23. Takeda T. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research. Neurobiol Aging 20: 105-110, 1999.
24. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly Y, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, and Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423, 2004.
25. Vandenberghe K, Goris M, Van Hecke P, Van Leemputte M, Vangerven L, and Hespel P. Long-term creatine intake is beneficial to muscle performance during resistance training. J Appl Physiol 83: 2055-2063, 1997.
26. Verbessem P, Lemiere J, Eijnde BO, Swinnen S, Vanhees L, Van Leemputte M, Hespel P, and Dom R. Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial. Neurology 61: 925-930, 2003.
27. Wallimann T, Wyss M, Brdiczka D, Nicolay K, and Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis. Biochem J 281: 21-40, 1992.
28. Weinert BT and Timiras PS. Theories of aging. J Appl Physiol 95: 1706-1716, 2003.
29. Wyss M and Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 112: 243-260, 2002.